Stay updated on NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now shows a newer ClinicalTrials.gov release revision number (v3.5.3 instead of v3.5.2) in the footer, indicating an update to the site’s versioning rather than the trial record details.
    Difference
    0.1%
    Check dated 2026-04-24T05:45:40.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:28:48.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a Resources section linking to the Genetic and Rare Diseases Information Center for Squamous cell Carcinoma of the Head and Neck.
    Difference
    0.2%
    Check dated 2026-04-02T15:25:39.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; Removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:48:06.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This change affects only the page revision label and does not alter study content or patient-facing information.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:08.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    A new page revision tag 'Revision: v3.4.2' has been added, and older notices including 'Revision: v3.4.1' and a government funding status notice have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:33:18.000Z thumbnail image

Stay in the know with updates to NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page.